Suzuken Co., Ltd.

Suzuken Co., Ltd.

SZUKF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.34B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Suzuken Co., Ltd.Suzuken Co., Ltd.11.42.76%8%-0.1
$10.48

Current Fair Value

39.6% downside

Overvalued by 39.6% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.34 Billion
Enterprise Value$-113,940,073,915.00
Annual dividend$0.54
Dividend yield2.76%
Earnings per Share$274.82
Beta0.23
Outstanding Shares134,961,180

Return

Return on Equity8.33%ROE
Return on Assets2.86%
Return on Invested Capital10.04%

Valuation & Multiples

P/E Ratio11.38P/E Ratio
PEG-49.47PEG
Price to Sales0.0Price to Sales
Price to Book Ratio0.01Price to Book Ratio
Enterprise Value to Revenue0.11
Enterprise Value to EBIT6.05
Enterprise Value to Net Income-4
Total Debt to Enterprise0.09
Debt to Equity0.06Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 12, 2026
EPS
$0.45
Est. $0.33
Revenue
$4.14 B
Est. $4.14 B

Next Earnings Call

Expected Date
February 10, 2027
EPS Estimate
$0.33
Consensus analyst estimate
Revenue Estimate
$4.36 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Suzuken Co., Ltd.

12,717 employees
CEO: Shigeru Asano

Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a wholesale distributor of pharmaceuticals, serving both domestic and international markets. The company's diverse activities are organized into four distinct ...

Questions & Answers